These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Performance of the BD FACSPresto near to patient analyzer in comparison with representative conventional CD4 instruments in Cameroon. Sagnia B, Mbakop Ghomsi F, Gutierrez A, Sosso S, Kamgaing R, Nanfack AJ, Nji N, Ambada G, Lissom A, Tchouangueu TF, Ngu Ndengkoh L, Domkam I, Nchinda G, Ndjolo A. AIDS Res Ther; 2020 Aug 17; 17(1):53. PubMed ID: 32799909 [Abstract] [Full Text] [Related]
7. Technical performance evaluation of the MyT4 point of care technology for CD4+ T cell enumeration. Mwau M, Kadima S, Mwende J, Adhiambo M, Akinyi C, Prescott M, Lusike J, Hungu J, Vojnov L. PLoS One; 2014 Aug 17; 9(9):e107410. PubMed ID: 25229408 [Abstract] [Full Text] [Related]
10. Multisite evaluation of point of care CD4 testing in Papua New Guinea. Malagun M, Nano G, Chevallier C, Opina R, Sawiya G, Kivavia J, Kalinoe A, Nathaniel K, Kaminiel O, Millan J, Carmone A, Dini M, Palou T, Topma K, Lavu E, Markby J. PLoS One; 2014 Aug 17; 9(11):e112173. PubMed ID: 25426710 [Abstract] [Full Text] [Related]
11. Field Performance of PIMA Point-of-Care Machine for CD4 Enumeration Under a Mobile HIV Counseling and Testing Program in Remote Fishing Communities of Lake Victoria, Uganda. Namuniina A, Lutwama F, Biribawa VM, Kizza D, Kabuubi BR, Kitandwe PK, Mpendo J, Nanvubya A, Ssempiira J, Nalutaaya A, Ssetaala A, Welsh S, Price MA, Kiwanuka N, Bagaya BS. AIDS Res Hum Retroviruses; 2019 Apr 17; 35(4):382-387. PubMed ID: 30560683 [Abstract] [Full Text] [Related]
13. The performance of BD FACSPresto™ for CD4 T-cell count, CD4% and hemoglobin concentration test in Ethiopia. Gebremicael G, Belay Y, Girma F, Abreha Y, Gebreegziabxier A, Tesfaye S, Messele Z, Assefa Y, Bellete B, Kassa D, Vojnov L. PLoS One; 2017 Apr 17; 12(4):e0176323. PubMed ID: 28448581 [Abstract] [Full Text] [Related]
15. Evaluation of portable point-of-care CD4 counter with high sensitivity for detecting patients eligible for antiretroviral therapy. Manabe YC, Wang Y, Elbireer A, Auerbach B, Castelnuovo B. PLoS One; 2012 Apr 17; 7(4):e34319. PubMed ID: 22536323 [Abstract] [Full Text] [Related]
17. Performance Evaluation of the MyT4 Technology for Determining ART Eligibility. Sitoe N, Macamo R, Meggi B, Tobaiwa O, Loquiha O, Bollinger T, Vojnov L, Jani I. PLoS One; 2016 Apr 17; 11(10):e0165163. PubMed ID: 27780216 [Abstract] [Full Text] [Related]